FCF co-organized, along with its companion YAFO Capital, the “ACCESS CHINA Biotech Discussion board” which was held on-line on June 21st & 24th, 2022.
ACCESS CHINA Biotech Discussion board is a quarterly company entry occasion collection between China and western biopharma. It’s the simplest deal-making platform for western pharma and biotech leaders trying to enter or broaden within the Chinese language market. The occasion helps western biopharma firms to effectively current their property on-line in entrance of 500+ biopharma firms / 2000+ BD administrators and healthcare VCs in China. It creates invaluable BD alternatives by instantly connecting and assembly with the fitting companions for improvement, licensing or business collaborations. We hosted 100 firm shows, 10 keynote speeches, 1000+ contributors, and 250+ 1×1 conferences. Licensing exercise in China has been steadily rising over time.